Results 21 to 30 of about 56,455 (308)

Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder

Journal of Neurology Neurosurgery & Psychiatry, 2021
Butler M, et al. J Neurol Neurosurg Psychiatry 2021;0:1–8. doi:10.1136/jnnp-2021-326924 Considerations for causality assessment of neurological and neuropsychiatric complications of SARSCoV-2 vaccines: from cerebral venous sinus thrombosis to functional ...
M. Butler, A. Tamborska, G. Wood, M. Ellul, R. Thomas, I. Galea, S. Pett, Bhagteshwar Singh, T. Solomon, T. Pollak, B. Michael, T. Nicholson   +11 more
semanticscholar   +1 more source

Periodontitis and atherosclerotic cardiovascular disease: A critical appraisal

Periodontology 2000, EarlyView., 2023
Abstract In spite of intensive research efforts driving spectacular advances in terms of prevention and treatments, cardiovascular diseases (CVDs) remain a leading health burden, accounting for 32% of all deaths (World Health Organization. “Cardiovascular Diseases (CVDs).” WHO, February 1, 2017, https://www.who.int/news‐room/fact‐sheets/detail ...
Maria Clotilde Carra, Hélène Rangé, Giuseppina Caligiuri, Philippe Bouchard   +3 more
wiley   +1 more source

Epidemiology of cerebral venous sinus thrombosis and cerebral venous sinus thrombosis with thrombocytopenia in the United States, 2018 and 2019

Research and Practice in Thrombosis and Haemostasis, 2022
Population‐based data about cerebral venous sinus thrombosis (CVST) are limited.
Amanda B. Payne, A. Adamski, Karon Abe, Nimia L Reyes, L. Richardson, W. Hooper, L. Schieve   +6 more
semanticscholar   +1 more source

From Skin to Sinus: A Rare Case of Cerebral Venous Sinus Thrombosis Caused by Occipital Subcutaneous Abscess. [PDF]

Cureus
Ishida K, Tanaka T, Saku A, Nakajima T, Kawashima H, Matsuno A.   +5 more
europepmc   +3 more sources

Cerebral venous sinus thrombosis [PDF]

Postgraduate Medical Journal, 2000
Summary Cerebral venous sinus thrombosis is a challenging condition because of its variability of clinical symptoms and signs. It is very often unrecognised at initial presentation. All age groups can be affected. Large sinuses such as the superior sagittal sinus are most frequently involved.
H, Allroggen, R J, Abbott
openaire   +2 more sources

Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19

European Journal of Case Reports in Internal Medicine, 2020
Coronavirus disease 19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We describe the case of a 59-year-old man who presented with headache, hypertension and a single episode of fever with no other symptoms.
C. Hughes, T. Nichols, Martin Pike, C. Subbe, Salah Elghenzai   +4 more
semanticscholar   +1 more source

Cerebral venous sinus thrombosis in pregnancy and puerperium: A comprehensive review

Brain Circulation, 2022
Cerebral venous sinus thrombosis (CVST) is a distinct neurological emergency caused by occlusion, either partial or complete, of the dural venous sinus and/or the cerebral veins.
H. Algahtani, Abdulrahman S. Bazaid, B. Shirah, Raghad N Bouges   +3 more
semanticscholar   +1 more source

Acute cerebral superior sagittal sinus thrombosis presenting with convulsive seizure in a paediatric patient. [PDF]

Pediatric Anesthesia and Critical Care Journal (PACCJ), 2023
Cerebral venous sinus thrombosis is a rare condition. Patients often; presents with complaints such as headache, unrest and vomiting. Convulsive seizure is the most common reason for admission in the pediatric age group.
Ş. Göktürk, Y. Göktürk
doaj   +1 more source

Foudroyant cerebral venous (sinus) thrombosis triggered through CLEC-2 and GPIIb/IIIa dependent platelet activation

Nature Cardiovascular Research, 2022
Cerebral venous (sinus) thrombosis (CVT) is an unusual manifestation of venous thrombosis causing severe neurological impairment and seizures1,2. Molecular mechanisms underlying CVT, potentially involving pathological platelet activation, are unknown ...
David Stegner, Vanessa Göb, Viola Krenzlin, S. Beck, K. Hemmen, Michael K. Schuhmann, B. Schörg, C. Hackenbroch, Frauke May, Philipp Burkard, Jürgen Pinnecker, A. Zernecke, P. Rosenberger, A. Greinacher, B. Pichler, K. Heinze, G. Stoll, B. Nieswandt   +17 more
semanticscholar   +1 more source

Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS‐CoV‐2 vaccination

European Journal of Neurology, 2021
High mortality rates have been reported in patients with cerebral venous sinus thrombosis (CVST) due to vaccine‐induced immune thrombotic thrombocytopenia (VITT) after vaccination with adenoviral vector SARS‐CoV‐2 vaccines.
Anita van de Munckhof, K. Krzywicka, D. Aguiar de Sousa, M. Sánchez van Kammen, M. Heldner, K. Jood, E. Lindgren, T. Tatlisumak, J. Putaala, J. K. Kremer Hovinga, S. Middeldorp, M. Levi, M. Arnold, J. Ferro, J. Coutinho   +14 more
semanticscholar   +1 more source